Last $3.75 USD
Change Today +0.85 / 29.31%
Volume 16.2K
VGEN On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

vaccinogen inc (VGEN) Snapshot

Open
$2.90
Previous Close
$2.90
Day High
$3.75
Day Low
$2.90
52 Week High
01/9/14 - $11.00
52 Week Low
07/30/14 - $2.51
Market Cap
120.2M
Average Volume 10 Days
12.3K
EPS TTM
--
Shares Outstanding
32.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VACCINOGEN INC (VGEN)

Related News

No related news articles were found.

vaccinogen inc (VGEN) Related Businessweek News

No Related Businessweek News Found

vaccinogen inc (VGEN) Details

Vaccinogen Inc., a biotechnology company, focuses on the development and commercialization of cancer vaccines and immunotherapeutic products for cancers and infectious diseases. It primarily offers OncoVAX, a cancer vaccine for the post-surgical treatment of Stage II colon cancer. The company was founded in 2007 and is headquartered in Frederick, Maryland.

9 Employees
Last Reported Date: 03/28/14
Founded in 2007

vaccinogen inc (VGEN) Top Compensated Officers

Founder, Chairman, Chief Executive Officer an...
Total Annual Compensation: $350.0K
Co-Founder, President, Acting Chief Financial...
Total Annual Compensation: $250.0K
Compensation as of Fiscal Year 2013.

vaccinogen inc (VGEN) Key Developments

Vaccinogen, Inc. Presents at RedChip Companies Emerging Growth Showcase, Jan-22-2014 03:00 PM

Vaccinogen, Inc. Presents at RedChip Companies Emerging Growth Showcase, Jan-22-2014 03:00 PM.

Vaccinogen, Inc. Appoints New Members to Medical Advisory Board

Vaccinogen, Inc. announced that noted pediatric neurosurgeon Benjamin S. Carson, M.D. and prominent oncologist Jan B. Vermorken, M.D., Ph.D. have joined the company's medical advisory board. Together, Drs. Carson and Vermorken bring broad knowledge of the global healthcare market and clinical oncology and previous clinical experience with OncoVAX(R), the Company's investigational cancer vaccine.

Vaccinogen, Inc. will Change its Ticker to VGEN from VACC

Effective March 14, 2013, Vaccinogen, Inc. will change its Pink Sheets LLC stock ticker symbol to VGEN from VACC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VGEN:US $3.75 USD +0.85

VGEN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VGEN.
View Industry Companies
 

Industry Analysis

VGEN

Industry Average

Valuation VGEN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 2.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VACCINOGEN INC, please visit www.vaccinogeninc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.